PTC THERAPEUTICS, INC. — Director's Dealing 2019

Jan 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-01-22

Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-22	Common Stock	A	4620	—	Acquired	22158	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-22	Stock Option (Right to Buy)	$33.02	A	265000	Acquired	2029-01-21	Common Stock (265000)	Direct
2019-01-22	Stock Option (Right to Buy)	$33.02	A	55000	Acquired	2029-01-21	Common Stock (55000)	Direct
2019-01-22	Stock Option (Right to Buy)	$33.02	A	26950	Acquired	2029-01-21	Common Stock (26950)	Indirect

Footnotes

F1: Restricted stock award granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020.

F2: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.

F3: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.